Author Question: The anesthesia provider would assign which physical status classification rating to a patient with ... (Read 44 times)

maychende

  • Hero Member
  • *****
  • Posts: 556
The anesthesia provider would assign which physical status classification rating to a patient with severe systemic disease, massive obesity, poorly controlled hypertension, or status postmyocardial infarction?
 a. ASA 1
  b. ASA 2
  c. ASA 3
  d. ASA 4

Question 2

The practice of applying cricoid pressure during endotracheal intubation was named for a British anesthesiologist named:
 a. Doppler
  b. Heimlich
  c. Korotkoff
  d. Sellick



Eazy416

  • Sr. Member
  • ****
  • Posts: 360
Answer to Question 1

c

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

Hip fractures are the most serious consequences of osteoporosis. The incidence of hip fractures increases with each decade among patients in their 60s to patients in their 90s for both women and men of all populations. Men and women older than 80 years of age show the highest incidence of hip fractures.

Did you know?

Hypertension is a silent killer because it is deadly and has no significant early symptoms. The danger from hypertension is the extra load on the heart, which can lead to hypertensive heart disease and kidney damage. This occurs without any major symptoms until the high blood pressure becomes extreme. Regular blood pressure checks are an important method of catching hypertension before it can kill you.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library